Application of FDG-PET in cervical cancer and endometrial cancer

Utility and future prospects

Yuya Nogami, Miho Iida, Kouji Banno, Iori Kisu, Masataka Adachi, Kanako Nakamura, Kiyoko Umene, Kenta Masuda, Eiichirou Tominaga, Kyoko Tanaka, Daisuke Aoki

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Positron-emission tomography (PET), a diagnostic imaging technique using an agent labeled with a positron-emitting radionuclide, may facilitate improved diagnosis and treatment in gynecological fields. A combined PET/computerized tomography (CT) scan can identify the precise anatomical location of a lesion based on accumulation of 18F-fluoro-D-glucose (FDG). FDG-PET and PET/CT have been used for detecting metastatic lesions and predicting prognosis in uterine cancer. PET has higher reliability in diagnosing lymph node metastases of uterine cancer than CT or MRI, and is considered most useful among non-invasive diagnostic imaging methods. Accumulation of FDG in lesions is indicative of a poor prognosis. Due to its limited spatial resolution, PET is not suitable has lower utility for detecting small lesions, and is not suitable for early-stage screening, and diagnosing primary lesions. Further improvements in diagnostic technology, including PET/MRI, investigation of new positron tracers, and analysis of data from various combinations of tracers are likely to make PET particularly useful for diagnosis and therapeutic strategy planning.

Original languageEnglish
Pages (from-to)585-592
Number of pages8
JournalAnticancer Research
Volume34
Issue number2
Publication statusPublished - 2014 Feb 1

Fingerprint

Endometrial Neoplasms
Uterine Cervical Neoplasms
Positron-Emission Tomography
Glucose
Uterine Neoplasms
Tomography
Diagnostic Imaging
Electrons
Radioisotopes
Lymph Nodes
Neoplasm Metastasis
Technology

Keywords

  • Cervical cancer
  • Endometrial cancer
  • FDG-PET
  • Review
  • Sensitivity
  • Specificity
  • SUV

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Application of FDG-PET in cervical cancer and endometrial cancer : Utility and future prospects. / Nogami, Yuya; Iida, Miho; Banno, Kouji; Kisu, Iori; Adachi, Masataka; Nakamura, Kanako; Umene, Kiyoko; Masuda, Kenta; Tominaga, Eiichirou; Tanaka, Kyoko; Aoki, Daisuke.

In: Anticancer Research, Vol. 34, No. 2, 01.02.2014, p. 585-592.

Research output: Contribution to journalArticle

Nogami, Y, Iida, M, Banno, K, Kisu, I, Adachi, M, Nakamura, K, Umene, K, Masuda, K, Tominaga, E, Tanaka, K & Aoki, D 2014, 'Application of FDG-PET in cervical cancer and endometrial cancer: Utility and future prospects', Anticancer Research, vol. 34, no. 2, pp. 585-592.
Nogami, Yuya ; Iida, Miho ; Banno, Kouji ; Kisu, Iori ; Adachi, Masataka ; Nakamura, Kanako ; Umene, Kiyoko ; Masuda, Kenta ; Tominaga, Eiichirou ; Tanaka, Kyoko ; Aoki, Daisuke. / Application of FDG-PET in cervical cancer and endometrial cancer : Utility and future prospects. In: Anticancer Research. 2014 ; Vol. 34, No. 2. pp. 585-592.
@article{a25ac897c378451c88e9f04c520c3a1e,
title = "Application of FDG-PET in cervical cancer and endometrial cancer: Utility and future prospects",
abstract = "Positron-emission tomography (PET), a diagnostic imaging technique using an agent labeled with a positron-emitting radionuclide, may facilitate improved diagnosis and treatment in gynecological fields. A combined PET/computerized tomography (CT) scan can identify the precise anatomical location of a lesion based on accumulation of 18F-fluoro-D-glucose (FDG). FDG-PET and PET/CT have been used for detecting metastatic lesions and predicting prognosis in uterine cancer. PET has higher reliability in diagnosing lymph node metastases of uterine cancer than CT or MRI, and is considered most useful among non-invasive diagnostic imaging methods. Accumulation of FDG in lesions is indicative of a poor prognosis. Due to its limited spatial resolution, PET is not suitable has lower utility for detecting small lesions, and is not suitable for early-stage screening, and diagnosing primary lesions. Further improvements in diagnostic technology, including PET/MRI, investigation of new positron tracers, and analysis of data from various combinations of tracers are likely to make PET particularly useful for diagnosis and therapeutic strategy planning.",
keywords = "Cervical cancer, Endometrial cancer, FDG-PET, Review, Sensitivity, Specificity, SUV",
author = "Yuya Nogami and Miho Iida and Kouji Banno and Iori Kisu and Masataka Adachi and Kanako Nakamura and Kiyoko Umene and Kenta Masuda and Eiichirou Tominaga and Kyoko Tanaka and Daisuke Aoki",
year = "2014",
month = "2",
day = "1",
language = "English",
volume = "34",
pages = "585--592",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "2",

}

TY - JOUR

T1 - Application of FDG-PET in cervical cancer and endometrial cancer

T2 - Utility and future prospects

AU - Nogami, Yuya

AU - Iida, Miho

AU - Banno, Kouji

AU - Kisu, Iori

AU - Adachi, Masataka

AU - Nakamura, Kanako

AU - Umene, Kiyoko

AU - Masuda, Kenta

AU - Tominaga, Eiichirou

AU - Tanaka, Kyoko

AU - Aoki, Daisuke

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Positron-emission tomography (PET), a diagnostic imaging technique using an agent labeled with a positron-emitting radionuclide, may facilitate improved diagnosis and treatment in gynecological fields. A combined PET/computerized tomography (CT) scan can identify the precise anatomical location of a lesion based on accumulation of 18F-fluoro-D-glucose (FDG). FDG-PET and PET/CT have been used for detecting metastatic lesions and predicting prognosis in uterine cancer. PET has higher reliability in diagnosing lymph node metastases of uterine cancer than CT or MRI, and is considered most useful among non-invasive diagnostic imaging methods. Accumulation of FDG in lesions is indicative of a poor prognosis. Due to its limited spatial resolution, PET is not suitable has lower utility for detecting small lesions, and is not suitable for early-stage screening, and diagnosing primary lesions. Further improvements in diagnostic technology, including PET/MRI, investigation of new positron tracers, and analysis of data from various combinations of tracers are likely to make PET particularly useful for diagnosis and therapeutic strategy planning.

AB - Positron-emission tomography (PET), a diagnostic imaging technique using an agent labeled with a positron-emitting radionuclide, may facilitate improved diagnosis and treatment in gynecological fields. A combined PET/computerized tomography (CT) scan can identify the precise anatomical location of a lesion based on accumulation of 18F-fluoro-D-glucose (FDG). FDG-PET and PET/CT have been used for detecting metastatic lesions and predicting prognosis in uterine cancer. PET has higher reliability in diagnosing lymph node metastases of uterine cancer than CT or MRI, and is considered most useful among non-invasive diagnostic imaging methods. Accumulation of FDG in lesions is indicative of a poor prognosis. Due to its limited spatial resolution, PET is not suitable has lower utility for detecting small lesions, and is not suitable for early-stage screening, and diagnosing primary lesions. Further improvements in diagnostic technology, including PET/MRI, investigation of new positron tracers, and analysis of data from various combinations of tracers are likely to make PET particularly useful for diagnosis and therapeutic strategy planning.

KW - Cervical cancer

KW - Endometrial cancer

KW - FDG-PET

KW - Review

KW - Sensitivity

KW - Specificity

KW - SUV

UR - http://www.scopus.com/inward/record.url?scp=84897072861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897072861&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 585

EP - 592

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2

ER -